化学
糖基化
糖基
药物发现
背景(考古学)
组合化学
药品
糖基供体
计算生物学
药物设计
立体化学
体内
基质(水族馆)
合理设计
生物化学
区域选择性
化学合成
化学生物学
秀丽隐杆线虫
糖基转移酶
小分子
酶
作者
Shaobin Chen,Bo Yang,Yaoyong Zeng,Shiming Li,Jialu Sang,Yang Han,Lijuan Zhu,Lingjun Zheng,Feng Zhu
摘要
Glycosylation of drug molecules offers an effective strategy to modulate pharmacological properties, and late-stage C–H glycosylation represents an appealing yet challenging strategy for direct molecular diversification. Current chemical and enzymatic methods often exhibit strong substrate dependence and limited control over site- and stereoselectivity, restricting their general applicability. Here, we describe a general platform that integrates highly site-selective aromatic C–H thianthrenation with stereoretentive palladium-catalyzed glycosyl cross-coupling, enabling access to both α- and β- C -glycosylated drug derivatives, including direct coupling with fully unprotected sugars. By exploiting complementary direct C–H and C–B thianthrenation pathways, this strategy enables regiodivergent synthesis of a broad range of C -glycosylated drug analogs. Within the context of organothianthrenium chemistry, this work establishes a stereospecific C(sp 3 )–C(sp 2 ) cross-coupling mode for glycosyl nucleophile. In vivo studies in Caenorhabditis elegans reveal that C- glycosylation of small-molecule drugs can substantially modulate antitumor efficacy and neuroprotection. Moreover, glycosyl stannanes are shown to exhibit intrinsic antitumor activity and therapeutic potential in Huntington’s disease models. Collectively, this late-stage C–H glycosylation platform provides a general and precise strategy for drug glycodiversification, accelerating sugar-based drug discovery and expanding the toolbox for late-stage functionalization of pharmaceutical molecules.
科研通智能强力驱动
Strongly Powered by AbleSci AI